Surrozen, Inc./DE Increase (Decrease) in Other Operating Assets and Liabilities, Net
Surrozen, Inc./DE (SRZN) reported Increase (Decrease) in Other Operating Assets and Liabilities, Net of -$31.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet · last filed 2026-08-06
- Surrozen, Inc./DE increase (decrease) in other operating assets and liabilities, net for the quarter ending 2026-06-30 was -$19.00K.
- Surrozen, Inc./DE increase (decrease) in other operating assets and liabilities, net for the quarter ending 2026-03-31 was -$12.00K.
- Surrozen, Inc./DE increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-12-31 was -$18.00K.
- Surrozen, Inc./DE increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-09-30 was -$18.00K.
- Surrozen, Inc./DE increase (decrease) in other operating assets and liabilities, net for fiscal 2025 was -$72.00K.
- Surrozen, Inc./DE increase (decrease) in other operating assets and liabilities, net for fiscal 2024 was -$71.00K.
- Surrozen, Inc./DE increase (decrease) in other operating assets and liabilities, net for fiscal 2023 was -$62.00K, a 116.36% decline from fiscal 2022.
- Surrozen, Inc./DE increase (decrease) in other operating assets and liabilities, net for fiscal 2022 was $379.00K, a 25.69% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Operating Assets and Liabilities, Net 3 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 6 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 9 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$31.00K 10-Q · filed 2026-08-06 | -$49.00K derived: sum of 3 quarters · filed 2026-08-06 | -$67.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$12.00K 10-Q · filed 2026-05-06 | -$30.00K derived: sum of 2 quarters · filed 2026-05-06 | -$48.00K derived: sum of 3 quarters · filed 2026-05-06 | -$67.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$36.00K derived: sum of 2 quarters · filed 2026-03-23 | -$55.00K derived: sum of 3 quarters · filed 2026-08-06 | -$72.00K 10-K · filed 2026-03-23 |
| 2025-09-30 | -$18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$37.00K derived: sum of 2 quarters · filed 2026-08-06 | -$54.00K 10-Q · filed 2025-11-07 | -$74.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$36.00K 10-Q · filed 2026-08-06 | -$56.00K derived: sum of 3 quarters · filed 2026-08-06 | -$78.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$17.00K 10-Q · filed 2026-05-06 | -$37.00K derived: sum of 2 quarters · filed 2026-05-06 | -$59.00K derived: sum of 3 quarters · filed 2026-05-06 | -$83.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$42.00K derived: sum of 2 quarters · filed 2026-03-23 | -$66.00K derived: sum of 3 quarters · filed 2026-03-23 | -$71.00K 10-K · filed 2026-03-23 |
| 2024-09-30 | -$22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$46.00K derived: sum of 2 quarters · filed 2025-11-07 | -$51.00K 10-Q · filed 2025-11-07 | -$75.00K derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | -$24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$29.00K 10-Q · filed 2025-08-08 | -$53.00K derived: sum of 3 quarters · filed 2025-08-08 | -$71.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$5.00K 10-Q · filed 2025-05-09 | -$29.00K derived: sum of 2 quarters · filed 2025-05-09 | -$47.00K derived: sum of 3 quarters · filed 2025-05-09 | -$69.00K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | -$24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$42.00K derived: sum of 2 quarters · filed 2025-03-31 | -$64.00K derived: sum of 3 quarters · filed 2025-03-31 | -$62.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | -$18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$40.00K derived: sum of 2 quarters · filed 2024-11-06 | -$38.00K 10-Q · filed 2024-11-06 | -$57.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | -$22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$20.00K 10-Q · filed 2024-08-12 | -$39.00K derived: sum of 3 quarters · filed 2024-08-12 | -$59.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $2.00K 10-Q · filed 2024-05-08 | -$17.00K derived: sum of 2 quarters · filed 2024-05-08 | -$37.00K derived: sum of 3 quarters · filed 2024-05-08 | $357.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | -$39.00K derived: sum of 2 quarters · filed 2024-04-10 | $355.00K derived: sum of 3 quarters · filed 2024-04-10 | $379.00K 10-K · filed 2024-04-10 |
| 2022-09-30 | -$20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $374.00K derived: sum of 2 quarters · filed 2023-11-08 | $398.00K 10-Q · filed 2023-11-08 | $22.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $394.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $418.00K 10-Q · filed 2023-08-09 | $42.00K derived: sum of 3 quarters · filed 2023-08-09 | $927.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $24.00K 10-Q · filed 2023-05-10 | -$352.00K derived: sum of 2 quarters · filed 2023-05-10 | $533.00K derived: sum of 3 quarters · filed 2023-05-10 | $533.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$376.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $509.00K derived: sum of 2 quarters · filed 2023-03-31 | $509.00K derived: sum of 3 quarters · filed 2023-03-31 | $510.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $885.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $885.00K derived: sum of 2 quarters · filed 2022-11-14 | $886.00K 10-Q · filed 2022-11-14 | $852.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $1.00K 10-Q · filed 2022-08-11 | -$33.00K derived: sum of 3 quarters · filed 2022-08-11 | |
| 2021-03-31 | $1.00K 10-Q · filed 2022-05-11 | -$33.00K derived: sum of 2 quarters · filed 2022-05-11 | ||
| 2020-12-31 | -$34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$10.00K 10-K · filed 2022-03-28 | ||
| 2020-09-30 | $24.00K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |